Acute motor axonal neuropathy: A frequent cause of acute flaccid paralysis in China
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
In northern China, annual epidemics of acute‐onset flaccid paralysis diagnosed clinically as Guillain‐Barré syndrome have been recognized for at least 20 years. On the basis of an historical analysis of more than 3,200 patients, distinctvie features include most cases occurring during the summer months among children and young adults, most of whom reside in rural areas. Of 90 patients with acute flaccid paralysis, 88 had a distinctive pattern that shares clinical and cerebrospinal fluid findings with demyelinating Guillain‐Barré syndrome, but that differs from Guillain‐Barré syndrome physiologically and pathologically. The clinical course is marked by rapidly progressive ascending tetraparesis, often with respiratory failure, but without fever, systemic illness, or sensory involvement. Cerebrospinal fluid is acellular, and elevations of protein content occur in the second or third week of illness. Electrodiagnostic studies show normal motor distal latencies and limb conduction velocities, but reduced compound muscle action potential amplitudes. Sensory nerve action potentials and, when elicitable, F waves are within the range of normal. Recovery is usually good. Autopsy studies have shown Wallerian‐like degeneration of motor fibers. These studies establish that this is a distinctive syndrome, distinguishable from poliomyelitis and demyelinating Guillain‐Barré syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Assessment of current diagnostic criteria for Guillain-Barr� syndrome
Asbury, A. K., & Cornblath, D. R. (1990) · Annals of Neurology · doi:10.1002/ana.410270707 · Cited by 1,905
Self-citationTHE INFLAMMATORY LESION IN IDIOPATHIC POLYNEURITIS
ASBURY, A. K., ARNASON, B. G., & ADAMS, R. D. (1969) · Medicine · doi:10.1097/00005792-196905000-00001 · Cited by 723
Self-citationAN ACUTE AXONAL FORM OF GUILLAIN-BARRÉE POLYNEUROPATHY
FEASBY, T. E., GILBERT, J. J., BROWN, W. F., BOLTON, C. F., HAHN, A. F., KOOPMAN, W. F., & ZOCHODNE, D. W. (1986) · Brain · doi:10.1093/brain/109.6.1115 · Cited by 538
A prospective study of acute idiopathic neuropathy. II. Antecedent events.
Winer, J. B., Hughes, R. A., Anderson, M. J., Jones, D. M., Kangro, H., & Watkins, R. P. (1988) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.5.613 · Cited by 284
Criteria for the diagnosis of the Guillain-Barré syndrome
Poser, C. M. (1981) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(81)90004-6 · Cited by 264
McKhann, G. M., Cornblath, D. R., Ho, T., Griffin, J. W., Li, C. Y., Bai, A. Y., Wu, H. S., Yei, Q. F., Zhang, W. C., Zhaori, Z., et al. (1991) · The Lancet · doi:10.1016/0140-6736(91)90606-p · Cited by 261
Self-citationCONDUCTION BLOCK AND DENERVATION IN GUILLAIN-BARRÉ POLYNEUROPATHY
BROWN, W. F., & FEASBY, T. E. (1984) · Brain · doi:10.1093/brain/107.1.219 · Cited by 252
Guillain–Barré syndrome in children: Clinical course, electrodiagnosis, and prognosis
Bradshaw, D. Y., & Jones, H. R. (1992) · Muscle & Nerve · doi:10.1002/mus.880150415 · Cited by 148
HLA‐B35 and acute axonal polyneuropathy following Campylobacter infection
Yuki, N., Sato, S., Itoh, T., & Miyatake, T. (1991) · Neurology · doi:10.1212/wnl.41.10.1561 · Cited by 65
Sabin, A. B. (1991) · European Journal of Epidemiology · doi:10.1007/bf00237353 · Cited by 24
Cited by
Hughes, R. A., & Cornblath, D. R. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67665-9 · Cited by 1,676
Self-citationWillison, H. J., Jacobs, B. C., & van Doorn, P. A. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00339-1 · Cited by 1,609
Yuki, N., & Hartung, H.-P. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1114525 · Cited by 1,260
Electrophysiological classification of guillain‐barré syndrome: Clinical associations and outcome
Hadden, R. D. M., Cornblath, D. R., Hughes, R. A. C., Zielasek, J., Hartung, H. ‐., Toyka, K. V., Swan, A. V., & The Plasma Exchange/Sandoglobulin Guillain‐Barré Syndrome Trial Group (1998) · Annals of Neurology · doi:10.1002/ana.410440512 · Cited by 942
Self-citationClinical features, pathogenesis, and treatment of Guillain-Barré syndrome
van Doorn, P. A., Ruts, L., & Jacobs, B. C. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70215-1 · Cited by 828
Campylobacter jejuni Infection and Guillain–Barré Syndrome
Rees, J. H., Soudain, S. E., Gregson, N. A., & Hughes, R. A. C. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511233332102 · Cited by 753
Schnaar, R. L., Gerardy-Schahn, R., & Hildebrandt, H. (2014) · Physiological Reviews · doi:10.1152/physrev.00033.2013 · Cited by 745
Peripheral neuropathies and anti-glycolipid antibodies
Willison, H. J. (2002) · Brain · doi:10.1093/brain/awf272 · Cited by 710
Sejvar, J. J., Kohl, K. S., Gidudu, J., Amato, A., Bakshi, N., Baxter, R., Burwen, D. R., Cornblath, D. R., Cleerbout, J., Edwards, K. M., et al. (2011) · Vaccine · doi:10.1016/j.vaccine.2010.06.003 · Cited by 652
Self-citationEpidemiology of peripheral neuropathy.
Martyn, C. N., & Hughes, R. A. (1997) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.62.4.310 · Cited by 597
Campylobacter Species and Guillain-Barré Syndrome
Nachamkin, I., Allos, B. M., & Ho, T. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.3.555 · Cited by 590
Self-citationGuillain–Barré and Miller Fisher syndromes—new diagnostic classification
the GBS Classification Group, Wakerley, B. R., Uncini, A., & Yuki, N. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.138 · Cited by 544
Acute motor axonal neuropathy: An antibody‐mediated attack on axolemma
Hafer‐Macko, C., Hsieh, S., Ho, T. W., Sheikh, K., Cornblath, D. R., Li, C. Y., McKhann, G. M., Asbury, A. K., & Griffin, J. W. (1996) · Annals of Neurology · doi:10.1002/ana.410400414 · Cited by 512
Self-citationYuki, N., Susuki, K., Koga, M., Nishimoto, Y., Odaka, M., Hirata, K., Taguchi, K., Miyatake, T., Furukawa, K., Kobata, T., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402391101 · Cited by 498
Clinical and Epidemiologic Features of Guillain‐Barré Syndrome
Hughes, R. A. C., & Rees, J. H. (1997) · The Journal of Infectious Diseases · doi:10.1086/513793 · Cited by 456
Mechanisms for the induction of autoimmunity by infectious agents
Wucherpfennig, K. W. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14235 · Cited by 435
Immune attack on the schwann cell surface in acute inflammatory demyelinating polyneuropathy
Hafer‐Macko, C. E., Sheikh, K. A., Li, C. Y., Ho, T. W., Cornblath, D. R., McKhann, G. M., Asbury, A. K., & Griffin, J. W. (1996) · Annals of Neurology · doi:10.1002/ana.410390512 · Cited by 416
Self-citationPathogenesis of Guillain–Barré syndrome
Hughes, R. A. C., Hadden, R. D. M., Gregson, N. A., & Smith, K. J. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00195-2 · Cited by 405
Pathology of the motor‐sensory axonal Guillain‐Barré syndrome
Griffin, J. W., Li, C. Y., Ho, T. W., Tian, M., Gao, C. Y., Xue, P., Mishu, B., Cornblath, D. R., Macko, C., McKhann, G. M., et al. (1996) · Annals of Neurology · doi:10.1002/ana.410390105 · Cited by 403
Self-citationHahn, A. F. (1998) · The Lancet · doi:10.1016/s0140-6736(97)12308-x · Cited by 395
Ogawara, K., Kuwabara, S., Mori, M., Hattori, T., Koga, M., & Yuki, N. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200010)48:4<624::aid-ana9>3.3.co;2-f · Cited by 333
Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barr� syndrome
Ho, T. W., Willison, H. J., Nachamkin, I., Li, C. Y., Veitch, J., Ung, H., Wang, G. R., Liu, R. C., Cornblath, D. R., Asbury, A. K., et al. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199902)45:2<168::aid-ana6>3.0.co;2-6 · Cited by 329
Self-citationYuki, N., Yamada, M., Koga, M., Odaka, M., Susuki, K., Tagawa, Y., Ueda, S., Kasama, T., Ohnishi, A., Hayashi, S., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1012 · Cited by 323
Kuwabara, S., Yuki, N., Koga, M., Hattori, T., Matsuura, D., Miyake, M., & Noda, M. (1998) · Annals of Neurology · doi:10.1002/ana.410440210 · Cited by 311
Immunopathogenesis and treatment of the guillain‐barré syndrome—part I
Hartung, H., Toyka, K. V., Pollard, J. D., & Harvey, G. K. (1995) · Muscle & Nerve · doi:10.1002/mus.880180202 · Cited by 288
Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barré syndrome
Griffin, J. W., Li, C. Y., Macko, C., Ho, T. W., Hsieh, S. T., Xue, P., Wang, F. A., Cornblath, D. R., McKhann, G. M., & Asbury, A. K. (1996) · Journal of Neurocytology · doi:10.1007/bf02284784 · Cited by 262
Self-citationKaida, K., Ariga, T., & Yu, R. K. (2009) · Glycobiology · doi:10.1093/glycob/cwp027 · Cited by 155
van der Mech�, F. G. A., & van Doorn, P. A. (1995) · Annals of Neurology · doi:10.1002/ana.410370704 · Cited by 131
Guillain-Barré syndrome and anti-ganglioside antibodies: A clinician-scientist’s journey
YUKI, N. (2012) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.88.299 · Cited by 109
Sialylated intravenous immunoglobulin suppress anti-ganglioside antibody mediated nerve injury
Zhang, G., Massaad, C. A., Gao, T., Pillai, L., Bogdanova, N., Ghauri, S., & Sheikh, K. A. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.05.020 · Cited by 38
“It is now widely accepted that there are two major forms of GBS: the demyelinating (Asbury et al., 1969; Prineas, 1981) and axonal (Hafer-Macko et al., 1996; McKhann et al., 1993; Ogawara et al., 2000) subtypes.”
Background
Metadata
- Authors
- McKhann, G. M., Cornblath, D. R., Griffin, J. W., Ho, T. W., Li, C. Y., Jiang, Z., Wu, H. S., Zhaori, G., Liu, Y., Jou, L. P., Liu, T. C., Gao, C. Y., Mao, J. Y., Blaser, M. J., Mishu, B., & Asbury, A. K.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1993-04
- Volume
- 33
- Issue
- 4
- Pages
- 333-342
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2118832722
- Cited by
- 625
- References
- 10
- FWCI
- 11.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.